Keros Therapeutics (NASDAQ:KROS) stock plunged 73% Thursday after the company said it has halted two arms of a Phase 2 clinical study of its drug cibotercept in patients with pulmonary arterial ...

An experimental, muscle-preserving drug from Biohaven fell short of its goal in a Phase 3 study of people with spinal muscular atrophy, but showed enough promise in its effects on body composition ...

Baxter International Inc. , a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the U.S., joining the previous five ...

CEO Barry Says Company Plans to Discontinue Another Late-Stage Study of the Drug “We took careful measures to enroll patients with mild-to-moderate AD. Despite that, the loss of cognition in the ...

Amgen (AMGN) fell sharply during Tuesday's intraday trading following the release of phase two trial results for its monthly obesity drug MariTide. Despite the medication demonstrating the ability ...

A highly anticipated obesity-drug candidate from biotech Amgen helped patients shed a significant amount of weight in a midstage study, but fell short of the loftier expectations of some investors.

The incidence of coagulation disorders related to cefazolin sodium, cefoperazone/sulbactam sodium ... Validation and evaluation of DRCD prediction models for study drugs Internal and external ...

Cassava Sciences’ SAVA stock shed more than 80% of market value on Monday after the company reported that its lead pipeline drug, simufilam, failed to meet the primary endpoints in a late study ...

announced this month that it got through the final hurdles with the U.S. Food and Drug Administration to get approval for a clinical study to look at veterans’ “real-world” cannabis use.

The year-long trial involving 592 people tested several different doses of the drug as a monthly or bi-monthly injection. Amgen said it also planned to study quarterly dosing. Novo's Wegovy led to ...

Warnings have been issued over commonly prescribed drugs could increase risk of dementia following a scientific study. Research suggested that regular use of certain types of commonly-prescribed ...